Stability of first trimester placental growth factor in serum and whole blood

被引:25
作者
Cowans, N. J. [1 ]
Alfthan, H. [2 ]
Stenman, U. H. [2 ]
Spencer, K. [1 ]
机构
[1] King George Hosp, Dept Clin Biochem, Prenatal Screening Unit, Goodmayes IG3 8YB, Essex, England
[2] Univ Helsinki, Cent Hosp, HUSLAB, Biomedicum, FIN-00014 Helsinki, Finland
关键词
PLGF; stability; screening; pre-eclampsia; ANGIOGENIC FACTORS; CRYSTAL-STRUCTURE; PREECLAMPSIA; PREDICTION; COMPLEX; PLASMA;
D O I
10.1002/pd.2894
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background Placental growth factor (PlGF) is a proposed first-trimester screening marker for pre-eclampsia. This study investigates the stability of PlGF in serum and whole blood at typical routine storage temperatures. Methods Serum pools were stored at refrigerator temperature, room temperature or 30 degrees C for up to 30 days, or exposed to up to six freeze-thaw cycles. Whole blood was stored at room temperature or 30 degrees C for up to 6 days. PlGF was quantified using a DELFIA Xpress analyser. Results Placental growth factor levels increased over time, seemingly because of the dissociation of PlGF bound to a soluble binding protein, sFlt-1. Increase was slow in serum at refrigerator temperature, remaining stable (less than 10% change from start point) for at least 30 days. At room temperature PlGF was stable for 3.3 days and at 30 degrees C for 1 day. Serum PlGF remained stable for at least six freeze-thaw cycles. In whole blood, instability was worse, being stable for only 19.4 h at room temperature and just 3.3 h at 30 degrees C. Conclusion Routine screening of sample handling requires careful monitoring. However, no extra precautions need to be taken when PlGF is used for pre-eclampsia screening run alongside existing first trimester aneuploidy screening programs that include hCG. Copyright c 2011 John Wiley & Sons, Ltd.
引用
收藏
页码:1193 / 1197
页数:5
相关论文
共 20 条
[1]   Global burden of maternal death and disability [J].
AbouZahr, C .
BRITISH MEDICAL BULLETIN, 2003, 67 :1-11
[2]   Maternal serum placental growth factor at 11+0 to 13+6 weeks of gestation in the prediction of pre-eclampsia [J].
Akolekar, R. ;
Zaragoza, E. ;
Poon, L. C. Y. ;
Pepes, S. ;
Nicolaides, K. H. .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2008, 32 (06) :732-739
[3]  
ANDERSON G, 1991, CLIN CHEM, V37, P398
[4]  
Bdolah Y, 2005, CROAT MED J, V46, P728
[5]  
Brosens I A, 1972, Obstet Gynecol Annu, V1, P177
[6]   Prevention of Preeclampsia and Intrauterine Growth Restriction With Aspirin Started in Early Pregnancy A Meta-Analysis [J].
Bujold, Emmanuel ;
Roberge, Stephanie ;
Lacasse, Yves ;
Bureau, Marc ;
Audibert, Francois ;
Marcoux, Sylvie ;
Forest, Jean-Claude ;
Giguere, Yves .
OBSTETRICS AND GYNECOLOGY, 2010, 116 (02) :402-414
[7]   Placenta growth factor: Identification and characterization of a novel isoform generated by RNA alternative splicing [J].
Cao, YH ;
Ji, WDR ;
Qi, P ;
Rosin, A ;
Cao, YM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 235 (03) :493-498
[8]   The crystal structure of placental growth factor in complex with domain 2 of vascular endothelial growth factor receptor-1 [J].
Christinger, HW ;
Fuh, G ;
de Vos, AM ;
Wiesmann, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (11) :10382-10388
[9]   PAPP-A and free β-hCG stability in first trimester serum using PerkinElmer AutoDELFIA® and DELFIA® Xpress systems [J].
Cowans, Nicholas J. ;
Stamatopoulou, Anastasia ;
Hellstrom, Johanna ;
Makela, Minna-Maarit ;
Spencer, Kevin .
PRENATAL DIAGNOSIS, 2010, 30 (02) :127-132
[10]   Screening for Pre-eclampsia-Lessons from Aneuploidy Screening [J].
Cuckle, H. S. .
PLACENTA, 2011, 32 :S42-S48